The buying interest on the pharma company's counter came after it launched 'Wanbury C RED', a Liposomal Iron formulation ...

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 10 best healthcare penny stocks to buy according to analysts.

A nne Romatowski noticed a small, soft something in the flesh below her collarbone just before Christmas. She wasn’t ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

According to the Centers for Medicare & Medicaid Services (CMS), the US healthcare sector accounted for approximately 17.6% ...

International aid organizations warn that the last remaining major hospital in southern Gaza is facing a lack of supplies and ...

Investigators analyzed blood samples from patients on dialysis to study uremic toxins in association with renal anemia pathogenesis.

Several other medical conditions can mimic the symptoms of low testosterone, including depression, sleep apnea, ...